SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-061700
Filing Date
2021-05-05
Accepted
2021-05-05 16:04:24
Documents
13
Period of Report
2021-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115217d1_8k.htm   iXBRL 8-K 24080
2 EXHIBIT 99.1 tm2115217d1_ex99-1.htm EX-99.1 86878
  Complete submission text file 0001104659-21-061700.txt   295828

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocul-20210505.xsd EX-101.SCH 3178
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocul-20210505_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocul-20210505_pre.xml EX-101.PRE 22705
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2115217d1_8k_htm.xml XML 3490
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36554 | Film No.: 21893158
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences